Perioperative plasma glypican-3 level may enable prediction of the risk of recurrence after surgery in patients with stage I hepatocellular carcinoma

Glypican-3 (GPC3) is a glycosylphosphatidylinositol-anchored cell surface protein overexpressed in hepatocellular carcinoma(HCC), and its overexpression is associated with poor prognosis. The diagnostic potential of GPC3 as a serum marker has been reported. In the present study, we evaluated the use...

Descripción completa

Detalles Bibliográficos
Autores principales: Ofuji, Kazuya, Saito, Keigo, Suzuki, Shiro, Shimomura, Manami, Shirakawa, Hirofumi, Nobuoka, Daisuke, Sawada, Yu, Yoshimura, Mayuko, Tsuchiya, Nobuhiro, Takahashi, Mari, Yoshikawa, Toshiaki, Tada, Yoshitaka, Konishi, Masaru, Takahashi, Shinichiro, Gotohda, Naoto, Nakamoto, Yasunari, Nakatsura, Tetsuya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Clinical Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5514954/
https://www.ncbi.nlm.nih.gov/pubmed/28035063
http://dx.doi.org/10.18632/oncotarget.14271

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5514954/
https://www.ncbi.nlm.nih.gov/pubmed/28035063
http://dx.doi.org/10.18632/oncotarget.14271

Ejemplares similares